Pharming B.V.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Industrial and Commercial Machinery and Equipment, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Pharming B.V.
Live alerts from global media, monitored by Business Radar
2025-01-07 (iex.nl)
DWS reports greater interest in Pharming
DWS Investment has reported a larger stake in Pharming Group. This emerged from a notification in the context of the Financial Supervision Act, dated January 3, 2025.
Read more
2024-12-10 (nd.nl)
Biotechnologist Pharming makes a price jump on Damrak after purchasing advice - Nederlas Dagblad. The quality newspaper of Christian Netherlands
Biotechnologist Pharming was one of the strongest risers on the Amsterdam stock exchange on Monday. The biotechnologist seemed to benefit from the buy recommendation issued by investment bank Jefferies.
Read more
2024-09-26 (iex.nl)
Micron effect on the stock market? AEX is heading for a nice opening, chip shares in Asia are flying
Opening indication AEX: +1.2%, after stock market celebration in Asia. Chip stocks in particular were not up to par, after Micron figures and SK Hynix news. And furthermore: Pharming, bitcoin and Switzerland.
Read more
2023-11-01 (iex.nl)
TomThumb | IEX.nl
IEX.nl is the investor platform in the Netherlands. Stay up to date with all relevant information about shares and other investment products. Investing - Price - Shares - Discussion.
Read more
2019-10-16 (iex.nl)
Live blog: Pharming and ASML
"Storm in glass of water Pharming." Nice ASML, but increasingly expensive. Brexit not yet a done deal and advice from Philips, Unibail, OCI and NIBC.
Read more
1998-04-27 (nrc.nl)
ABN Amro and NPM Capital invest in Pharming
ROTTERDAM, APRIL 28. The investment companies ABN Amro Participaties and NPM Capital have invested 13 and 11 million guilders respectively in the Leiden biotechnological company Pharming. The company became independent in April '95, and which received publicity at the time due to the transgenic bull H
Read more
1998-04-27 (nrc.nl)
ABN Amro and NPM Capital invest in Pharming
ROTTERDAM, APRIL 28. The investment companies ABN Amro Participaties and NPM Capital have invested 13 and 11 million guilders respectively in the Leiden biotechnological company Pharming. The company became independent in April '95, and which received publicity at the time due to the transgenic bull H
Read more
1998-04-27 (nrc.nl)
ABN Amro and NPM Capital invest in Pharming
ROTTERDAM, APRIL 28. The investment companies ABN Amro Participaties and NPM Capital have invested 13 and 11 million guilders respectively in the Leiden biotechnological company Pharming. The company became independent in April '95, and which received publicity at the time due to the transgenic bull H
Read more
1998-04-27 (nrc.nl)
ABN Amro and NPM Capital invest in Pharming
ROTTERDAM, APRIL 28. The investment companies ABN Amro Participaties and NPM Capital have invested 13 and 11 million guilders respectively in the Leiden biotechnological company Pharming. The company became independent in April '95, and which received publicity at the time due to the transgenic bull H
Read more